Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination
Rahul K. Suryawanshi, Irene P. Chen, Tongcui Ma, et al.
Nature (2022) Vol. 607, Iss. 7918, pp. 351-355
Open Access | Times Cited: 181

Showing 26-50 of 181 citing articles:

Durable reprogramming of neutralizing antibody responses following Omicron breakthrough infection
Wen Shi Lee, Hyon‐Xhi Tan, Arnold Reynaldi, et al.
Science Advances (2023) Vol. 9, Iss. 29
Open Access | Times Cited: 20
Syrian hamster convalescence from prototype SARS-CoV-2 confers measurable protection against the attenuated disease caused by the Omicron variant
Kathryn A. Ryan, Kevin R. Bewley, Robert J. Watson, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 4, pp. e1011293-e1011293
Open Access | Times Cited: 18
A single inactivating amino acid change in the SARS-CoV-2 NSP3 Mac1 domain attenuates viral replication in vivo
Taha Y. Taha, Rahul K. Suryawanshi, Irene P. Chen, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 8, pp. e1011614-e1011614
Open Access | Times Cited: 17
Biparatopic antibody BA7208/7125 effectively neutralizes SARS-CoV-2 variants including Omicron BA.1-BA.5
Yanqun Wang, An Yan, Deyong Song, et al.
Cell Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 16
Long-term adaptive response in COVID-19 vaccine recipients and the effect of a booster dose
Luca Perico, Marta Todeschini, Federica Casiraghi, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 15
Generation and characterization of a humanized ACE2 mouse model to study long‐term impacts of SARS‐CoV‐2 infection
Chang‐Yong Choi, Kundlik Gadhave, Jason Villano, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 1
Open Access | Times Cited: 6
SARS-CoV-2 Vaccines: The Advantage of Mucosal Vaccine Delivery and Local Immunity
Joshua Tobias, Peter Steinberger, Joy Wilkinson, et al.
Vaccines (2024) Vol. 12, Iss. 7, pp. 795-795
Open Access | Times Cited: 5
The Mac1 ADP-ribosylhydrolase is a Therapeutic Target for SARS-CoV-2
Rahul K. Suryawanshi, Priyadarshini Jaishankar, G.J. Correy, et al.
(2025)
Open Access
The Mac1 ADP-ribosylhydrolase is a Therapeutic Target for SARS-CoV-2
Rahul K. Suryawanshi, Priyadarshini Jaishankar, G.J. Correy, et al.
(2025)
Open Access
Characterization of Vaccine-Enhanced Humoral Immune Responses Against Emergent SARS-CoV-2 Variants in a Convalescent Cohort
Jared Sheehan, Amber J. Trauth, Michael E. Hagensee, et al.
Pathogens (2025) Vol. 14, Iss. 1, pp. 44-44
Open Access
Recombinant XBB.1.5 boosters induce robust neutralization against KP.2- and KP.3-included JN.1 sublineages
H. J. Yang, Xuemei He, Shi H, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access
Molecular adaptations during viral epidemics
Nash D. Rochman, Yuri I. Wolf, Eugene V. Koonin
EMBO Reports (2022) Vol. 23, Iss. 8
Open Access | Times Cited: 24
A spike-trimer protein-based tetravalent COVID-19 vaccine elicits enhanced breadth of neutralization against SARS-CoV-2 Omicron subvariants and other variants
Rui Wang, Hongpeng Huang, Chulin Yu, et al.
Science China Life Sciences (2022) Vol. 66, Iss. 8, pp. 1818-1830
Open Access | Times Cited: 24
Do pathogens always evolve to be less virulent? The virulence–transmission trade-off in light of the COVID-19 pandemic
Ádám Kun, András G. Hubai, Adrienn Král, et al.
Biologia Futura (2023) Vol. 74, Iss. 1-2, pp. 69-80
Open Access | Times Cited: 13
A Gamma-adapted subunit vaccine induces broadly neutralizing antibodies against SARS-CoV-2 variants and protects mice from infection
Lorena M. Coria, Juan M. Corchado, Agostina Demaría, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
The Mac1 ADP-ribosylhydrolase is a Therapeutic Target for SARS-CoV-2
Rahul K. Suryawanshi, Priyadarshini Jaishankar, G.J. Correy, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 4
COVID-19 Vaccine Booster Strategies for Omicron SARS-CoV-2 Variant: Effectiveness and Future Prospects
Dorota Zarębska‐Michaluk, Chenlin Hu, Michał Brzdęk, et al.
Vaccines (2022) Vol. 10, Iss. 8, pp. 1223-1223
Open Access | Times Cited: 20
Can the SARS-CoV-2 Omicron Variant Confer Natural Immunity against COVID-19?
Abdul Hawil Abas, Siti Marfuah, Rinaldi Idroes, et al.
Molecules (2022) Vol. 27, Iss. 7, pp. 2221-2221
Open Access | Times Cited: 19
Memory B Cells and Memory T Cells Induced by SARS-CoV-2 Booster Vaccination or Infection Show Different Dynamics and Responsiveness to the Omicron Variant
Setsuko Mise‐Omata, Mari Ikeda, Masaru Takeshita, et al.
The Journal of Immunology (2022) Vol. 209, Iss. 11, pp. 2104-2113
Open Access | Times Cited: 19
Low SARS-CoV-2 viral load among vaccinated individuals infected with Delta B.1.617.2 and Omicron BA.1.1.529 but not with Omicron BA.1.1 and BA.2 variants
Sivaprakasam T. Selvavinayagam, Yean K. Yong, Narcisse Joseph, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 18
Comparison of antibody responses to SARS-CoV-2 variants in Australian children
Zheng Quan Toh, Nadia Mazarakis, Jill Nguyen, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 18
Omicron infection-associated T- and B-cell immunity in antigen-naive and triple-COVID-19-vaccinated individuals
Joana Barros‐Martins, Swantje I. Hammerschmidt, Gema Morillas Ramos, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 11
Dynamic variations in COVID-19 with the SARS-CoV-2 Omicron variant in Kazakhstan and Pakistan
Qianqian Cui, Zheng‐Li Shi, Duman Yimamaidi, et al.
Infectious Diseases of Poverty (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 10
Omicron BA.1 breakthrough infections in inactivated COVID-19 vaccine recipients induced distinct pattern of antibody and T cell responses to different Omicron sublineages
Li Guo, Qiao Zhang, Jingchuan Zhong, et al.
Emerging Microbes & Infections (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 10
Three in one: An effective and universal vaccine expressing heterologous tandem RBD trimer by rabies virus vector protects mice against SARS-CoV-2
Jingbo Huang, Weiqi Wang, Hailun Li, et al.
Antiviral Research (2024) Vol. 227, pp. 105905-105905
Closed Access | Times Cited: 3

Scroll to top